Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Related Searches: Validation Phase I Development Testing
April 24, 2014
Solaris revenue up 67% in the quarter  Read More »
April 24, 2014
Cymbalta and Evista patent expirations impact results  Read More »
April 24, 2014
Employs Novozymes' VELTIS technology for optimized dosing  Read More »
April 24, 2014
Phase I trial to employ prediction marker using Evotec's Proteome platform  Read More »
April 24, 2014
Will support cancer drug development programs  Read More »
April 24, 2014
Will promote Crown’s translational services to clients in Japan  Read More »
April 24, 2014
Will work to optimize Biogen’s clinical development processes   Read More »
April 23, 2014
Brazilian Development Partnerships drive growth  Read More »
April 23, 2014
Revenues up 97% driven by Sovaldi sales  Read More »
April 23, 2014
Revenues up 7% in the quarter   Read More »
April 23, 2014
Appoints Invenium Pharmacology as exclusive agent  Read More »
April 23, 2014
51% growth driven by MS franchise  Read More »
April 23, 2014
Samsung to manufacture several BMS biologics at Incheon site   Read More »
April 22, 2014
To develop and commercialize Chk1 program  Read More »
April 22, 2014
Aims to deliver simplified reporting and enhanced visualizations for researchers  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On